REVIEW ARTICLES
Parasporins as new natural anticancer agents: a review
Almas Okassov, Armen Nersesyan, Sakae Kitada, Alexander Ilin; pp 5-16 (Pubmed Abstract, PDF)
Fighting against human papillomavirus: the 25-year old contribution of the University of Crete School of Medicine
Ioannis N. Mammas, Demetrios A. Spandidos; pp 17-21 (Pubmed Abstract, PDF)
ORIGINAL ARTICLES
BREAST CANCER
A retrospective analysis of adjuvant CAF, AC-T and TAC regimens in triple negative early stage
breast cancer
Hakan Buyukhatipoglu, Taner Babacan, Neyran Kertmen, Ozan Balakan, Ali Suner, Ozturk Ates, Furkan Sarici, Alma Aslan, Omer Diker, Vildan Tasdemir, Yavuz Ozisik, Kadri Altundag; pp 22-27 (Pubmed Abstract, PDF)
Progesterone receptor status in determining the prognosis of estrogen receptor positive/ HER2 negative breast carcinoma patients
Oznur Bal, UlkuYalcintas Arslan, Ayse Durnali, Ummugul Uyetrk, Ayse Demirci, Didem Tastekin, Ahmet Ekinci,Onur Esbah, Ibrahim Turker, Ozlem Uysal Sonmez, Berna Oksuzoglu;pp 28-34 (Pubmed Abstract, PDF)
Molecular subtypes in patients with inflammatory breast cancer; A single center experience
Neyran Kertmen, Taner Babacan, Ozge Keskin, Mustafa Solak, Furkan Sarici, Serkan Akin, Zafer Arik,
Alma Aslan, Ozturk Ates, Sercan Aksoy, Yavuz Ozisik, Kadri Altundag; pp 35-39 (Pubmed Abstract, PDF)
Analysis of the cytological features supporting the diagnosis of lobular breast cancer. Factors associated with equivocal diagnoses
Smaroula N. Divani, Nikolaos D. Kardasis; pp 40-44 (Pubmed Abstract, PDF)
Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer
Nilufer Avci, Adem Deligonul, Sahsine Tolunay, Erdem Cubukcu, Omer Fatih Olmez, Arife Ulas, Mustafa Hartavi, Ender Kurt, Turkkan Evrensel; pp 45-49 (Pubmed Abstract, PDF)
The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+ breast cancer patients
Taner Babacan, Ozan Balakan, Taha Y Kuzan, Furkan Sarici, Emre Koca, Neyran Kertmen, Ibrahim Petekkaya, Kadri Altundag; pp 50-56 (Pubmed Abstract, PDF)
Mammary gland epithelial changes in thyroidectomized female rats
Vasilios Pergialiotis, Georgios Agrogiannis, Eleana Gkioka, Georgios D Vlachos, Despina Perrea, Konstantinos Kontzoglou; pp 57-61 (Pubmed Abstract, PDF)
GASTROINTESTINAL CANCER
Magnetic resonance imaging in restaging rectal cancer after neoadjuvant chemoradiotherapy
Shufang Zhan, Xingxing Wang, Xuefeng Huang, Hongbo Zhu; pp 62-67 (Pubmed Abstract, PDF)
Determinants of survival after liver resection for metastatic colorectal carcinoma
Angela Parau, Nicolae Todor, Liviu Vlad; pp 68-77 (Pubmed Abstract, PDF)
High levels of platelet/lymphocyte ratio are associated with metastatic gastric cancer
Suleyman Cetinkunar, Hakan Guzel, Ismail Emre Gokce, Hasan Erdem, Saygi Gulkan, Recep Aktimur,
Bertan Kucuk, Inanc Imamoglu, Hulagu Kargici; pp 78-83 (Pubmed Abstract, PDF)
Augmenter of liver regeneration gene expression in human colon cancer cell lines and clinical tissue samples
Elisavet Gatzidou, Marina Mantzourani, Constantinos Giaginis, Athina Giagini, Efstratios Patsouris, Gregory Kouraklis, Stamatios Theocharis; pp 84-91 (Pubmed Abstract, PDF)
Evaluation of clinical, morphopathological and therapeutic prognostic factors in rectal cancer. Experience of a tertiary oncology center
CatalinVlad, Paul Kubelac, Diana Vlad, Alexanrdu Irimie, Patriciu Achimas Cadariu; pp 92-99 (Pubmed Abstract, PDF)
Involvement of leptin receptors expression in proliferation and neoangiogenesis in colorectal carcinoma
Velimir S. Milosevic, Filip C. Vukmirovic, Miljan S. Krstic, Miljan M. Zindovic, Dragos LJ Stojanovic, Snezana A. Jancic; pp 100-108 (Pubmed Abstract, PDF)
Meta analysis of the association of cholesterol with pancreatic carcinoma risk
Xiangjun Chen, Taoyou Zhou, Min Chen; pp 109-113 (Pubmed Abstract, PDF)
The prognostic value of FOXP3+ T regulatory cells in colorectal cancer
CatalinVlad, Paul Kubelac, Bogdan Fetica, Diana Vlad, Alexandru Irimie, Patriciu Achimas-Cadariu; pp 114-119 (Pubmed Abstract, PDF)
The proinflammatory effect and molecular mechanism of IL-17 in the intestinal epithelial cell line HT-29
Ming Zhang, Ge Wang, Yun Tao, Hua Zhang; pp 120-127 (Pubmed Abstract, PDF)
KRAS discordance between primary and metastatic tumor in patients with metastatic colorectal carcinoma
Ahmet Siyar Ekinci, Umut Demirci, Berna Cakmak Oksuzoglu, Ayse Ozturk, Onur Esbah, Tahsin Ozatli, Burcin Celik, Burcin Budakoglu, Ibrahim Turker, Oznur Bal, Nedim Turan;pp128-135 (Pubmed Abstract, PDF)
LUNG CANCER
EGFR mutations in patients with non small-cell lung cancer in Bulgaria and treatment with gefitinib
Danail Damyanov, Krassimir Koynov, Emilia Naseva, Stoyan Bichev; pp 136-141 (Pubmed Abstract, PDF)
Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens
Haimiao Xu, Wenyong Sun, Gu Zhang, Yue Cheng; pp 142-145 (Pubmed Abstract, PDF)
Accelerated hypofractionated thoracic radiotherapy in limited disease small cell lung cancer : comparison with the results of conventionally fractionated radiotherapy
Joanna Socha, Agnieszka Guzowska, Dobromira Tyc-Szczepaniak, Marek Wierzchowski, Arkadiusz Sprawka, Aleksandra Szczesna, Lucyna Kepka; pp 146-157 (Pubmed Abstract, PDF)
Stereotactic body radiotherapy for colorectal lung oligometastases: preliminary single-institution results
Claudia Carvajal, Arturo Navarro-Martin, Jon Cacicedo, Ricard Ramos, Ferran Guedea; pp 158-165 (Pubmed Abstract, PDF)
Correlation of tumor size as independent factor and disease stage with local recurrence of non-small cell lung carcinoma and its operability
Dejan Stojiljkovic, Nada Santrac, Tanja Stojiljkovic, Nebojsa Miletic, Dusica Gavrilovic; pp 166-172 (Pubmed Abstract, PDF)
GENITOURINARY CANCERS
Changes in the gene expression profile of the bladder cancer cell lines after treatment with Helix lucorum and Rapana venosa hemocyanin
Olga Antonova, Lilia Yossifova, Rada Staneva, Stefan Stevanovic, Pavlina Dolashka, Draga Toncheva; pp 180-187 (Pubmed Abstract, PDF)
Expression and significance of FOXP1, HIF-1a and VEGF in renal clear cell carcinoma
Li Wan, Jingyong Huang, Jianou Chen, Rongrong Wang, Chunge Dong, Shanshan Lu, Xiuling Wu; pp 188-195 (Pubmed Abstract, PDF)
HEAD AND NECK CANCER
Τhe first implementation of IMRT technique for head & neck and prostate cancer patients in public
sector in Greece: feasibility, treatment planning and dose delivery verification using the delta 4PT Pre-Treatment volumetric quality assurance system
Vassilis Kouloulias, Christos Antypas, Zoi Liakouli, Christina Armpilia, Anna Zygogianni, Ioannis Floros, Maria Tolia, John Kokakis, John Kouvaris; pp 196-205 (Pubmed Abstract, PDF)
Assessment of radiotherapy combined with adjuvant chemotherapy in the treatment of patients with advanced nasopharyngeal carcinoma: a prospective study
Fei Kong, Baizhen Cai, Shaomin Lin, Jian Zhang, Yiming Wang, Qiang Fu; pp 206-211 (Pubmed Abstract, PDF)
Expression patterns of claudins 1, 4, and 7 and their prognostic significance in nasopharyngeal carcinoma
Dinc Suren, Mustafa Yildirim, Vildan Kaya, Ruksan Elal, Omer Tarik Selcuk, Ustun Osma, Mustafa Yildiz, Seyda Gunduz, Cem Sezer; pp 212-217 (Pubmed Abstract, PDF)
LIVER CANCER
Sorafenib inhibits liver cancer growth by decreasing mTOR, AKT, and PI3K expression
Chi-zhi Zhang, Xiao-dong Wang, Hong-wei Wang, YueCai, Li-qin Chao; pp 218-222 (Pubmed Abstract, PDF)
Is radiofrequency ablation equal to surgical re-resection for recurrent hepatocellular carcinoma meeting the Milan criteria? A meta-analysis
Cheng-shuo Zhang, Jia-lin Zhang, Xiao-hang Li ,Le Li, Xin Li, Xiang-yu Zhou; pp 223-230 (Pubmed Abstract, PDF)
GYNECOLOGICAL CANCERS
Mortality from cervical cancer in Serbia in the period 1991-2011
Tamara Naumovic, Dragan Miljus, Milica Djoric, Snezana Zivkovic, Zivko Perisic; pp 231-234 (Pubmed Abstract, PDF)
MELANOMA
Vitamin D receptor FokI, BsmI, TaqI, ApaI, and EcoRV polymorphisms and susceptibility to melanoma: a meta-analysis
Young Ho Lee, Gwan Gyu Song; pp 235-243 (Pubmed Abstract, PDF)
PERITONEAL CANCER
Clinical history of patients with peritoneal carcinomatosis exluded from cytoreductive surgery & HIPEC
John Spiliotis, Evgenia Halkia, Athanassios Rogdakis, Kalliopi Kastrinaki, Evangelos Lianos, Elias Efstathiou; pp 244-247 (Pubmed Abstract, PDF)
CNS TUMORS
Dosimetric comparison of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for cerebral malignant gliomas
Ruifeng Zheng, Ruitai Fan, Haiying Wen, Junbo Luo, Yang Yang; pp 248-252 (Pubmed Abstract, PDF)
67kDa laminin receptor regulates the activation of MAPKs through DUSPs in glioma cell line U251
Li Jiang, Can Zhang, Yue Wu, Ying Jiang, YonghuaJi, Fuxue Chen; pp 253-260 (Pubmed Abstract, PDF)
HEMATOLOGICAL MALIGNANCIES
LEP and LEPR polymorphisms in non-Hodgkin lymphoma risk: A systematic review and pooled analysis
Hai-Yan Lin, Hui Shi, Chun-Yan Li, Quan-Chi Chen, Tian-Bao Huang, Peng-Cheng Liu, Lie-ming Lou; pp 261-268 (Pubmed Abstract, PDF)
CHONDROSARCOMA
Histone deacetylase inhibitors repress chondrosarcoma cell proliferation
Jiaxue Zhu, Jianhua Gu, Jie Ma, Zhixing Xu, Hairong Tao; pp 269-274 (Pubmed Abstract, PDF)
NURSING ONCOLOGY
Nurses’ practices in targeted therapies in Turkey
Sultan Kav, Sevcan Atay; pp 275-279 (Pubmed Abstract, PDF)
SCREENING MARKERS
Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinoma
Betul Celik, Arzu Didem Yalcin, Gizem Esra Genc, Saadet Gumuslu; pp 280-286 (Pubmed Abstract, PDF)
POLYMORPHISMS AND CANCER RISK
Polymorphisms of GSTA1 contribute to elevated cancer risk: evidence from 15 studies
Qiwen Deng, Bangshun He, Yuqin Pan, Huiling Sun, Xian Liu, Jie Chen, Houqun Ying, Kang Lin, Hongxin Peng, Shukui Wang; pp 287-295 (Pubmed Abstract, PDF)
Association between estrogen receptor 1 (ESR1) genetic variations and cancer risk: a meta-analysis
Huiling Sun, Qiwen Deng, Yuqin Pan, Bangshun He, Houqun Ying, Jie Chen, Xian Liu, Shukui Wang; pp 296-308 (Pubmed Abstract, PDF)
Association of rs712 polymorphism in Kras gene 3’-untranslated region and cancer risk: A meta-analysis
Huiling Sun, Qiwen Deng, Yuqin Pan, Bangshun He, Houqun Ying, Jie Chen, Xian Liu, Shukui Wang Wei-Hai Zhao, Xiao-Fei Qu, Zhe-Gang Xing, Li-Qin Zhao, Long Qin, Chao Lv; pp 309-316 (Pubmed Abstract, PDF)
MISCELLANEOUS
The effect of anaesthetic management on neutrophil gelatinase associated lipocalin (NGAL) levels after robotic surgical oncology
Mihaly Orsolya, Mihaly Attila-Zoltan, Vitalie Gherman, Florin Zaharie, Sorana Bolboaca, Cipriana Chira, Constantin Bodolea, Ciprian Tomuleasa, Alexandru Irimie, Ioan Coman, Daniela Ionescu; pp 317-324 (Pubmed Abstract, PDF)
The correlation between a chronic inflammatory marker Tartrate-Resistant Acid Phosphatase 5a with
cancer cachexia
Yi-Ying Wu, Tsu-Yi Chao, Hsin-Yi Liu, Tzu-Chuan Huang, Jia-Hong Chen, Ming-Shen Dai, Anthony Janckila, Shiue-Wei Lai, Ping-Ying Chang; pp 325-331 (Pubmed Abstract, PDF)
A 12-year experience at a tertiary hospital on patients with multiple primary malignant neoplasms
Ioannis Papaconstantinou, Dionysios S. Mantzos, Konstantina Asimakoula, Vasiliki Michalaki, Agathi Kondi-Pafiti; pp 332-337 (Pubmed Abstract, PDF)
Retrospective evaluation of totally implantable venous access port devices: Early and late complications
Selami Gurkan, Selcuk Seber, Ozcan Gur, TarkanYetisyigit, Mehmet Okan Donbaloglu, Demet Ozkaramanli Gur; pp 338-345 (Pubmed Abstract, PDF)
COMMENTARY
Proceedings of the 9th International Congress on Peritoneal Surface Malignancies, October 9th –11th 2014, Amsterdam
Charalampos Seretis, Umar Shariff, Tirumularaju Raju, Evgenia Halkia, John Spiliotis, Haney Youssef; pp 346-347 (Pubmed Abstract, PDF)
LETTERS TO THE EDITOR
A systemic late recurrence after the first operation in a patient diagnosed with early-stage breast cancer: the latest recurrence in the literature
Ozge Durdu Keskin, Neyran Kertmen, Yusuf Karakas, Taner Babacan,Zafer Arik, Kadri Altundag, Ibrahim Gullu; p 348 (Pubmed Abstract, PDF)
Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab
Ozturk Ates, Veli Sunar, Taner Babacan, Serkan Akin, Neyran Kertmen, Kadri Altundag; p 349 (Pubmed Abstract, PDF)
Targeted immunotherapies overtaking emerging oncology market value based growth
Mihajlo B. Jakovljevic; pp 350-351 (Pubmed Abstract, PDF)
Extracranial recurrence in the bone marrow of adult medulloblastoma patient – a therapeutic trap
Wojciech Rogowski, Ewa Wachuła; p 352 (Pubmed Abstract, PDF)
Intra-carotid chemotherapy of mandible osteosarcoma
Peng Zhao, Cheng Liu, Yanjun Zeng; p 353 (Pubmed Abstract, PDF)
HISTORY OF ONCOLOGY
René-Théophile-Hyacinthe Laennec (1781–1826) and the description of metastatic pulmonary melanoma
Marianna Karamanou, Alexandros J. Stratigos, Zenia Saridaki, Gregory Tsoucalas, George Androutsos; pp 354-356 (Pubmed Abstract, PDF)
